An expert discusses how she managed an unusual case of a patient with high myopia with angle closure and elevated intraocular pressure (IOP) through cataract extraction with toric lens implantation, combined with canaloplasty and endocyclophotocoagulation (ECP) to address both the refractive needs and anatomical causes of the condition.
A panelist discusses how the iDose implant is surgically placed into the scleral wall with precision, can be repositioned if needed, and remains stable even after procedures like goniotomy, making it a versatile option in glaucoma care.
An expert discusses how she treated a 70-year-old patient with high myopia with mild glaucoma and cataracts using a light adjustable lens combined with an iDose travoprost sustained-release implant to achieve spectacle-free and drop-free outcomes while maintaining excellent pressure control.
A panelist discusses how procedural pharmaceuticals like Durysta and iDose offer sustained drug delivery solutions tailored to patient needs, providing long-term efficacy and reducing dependence on daily eye drops.
A panelist discusses how interventional glaucoma emphasizes early, proactive treatment strategies to reduce IOP and medication burden while addressing patient adherence and long-term disease control.
An expert discusses how modern glaucoma treatment has evolved from a reactive one-size-fits-all approach of multiple drops followed by major surgery to a proactive, individualized strategy that emphasizes early procedural interventions to minimize medication burden and vision loss.
From lids to retina, the 2-day event on September 26 and 27, 2025, at the Margaritaville Hollywood Beach Resort, Florida, offers a collaborative and comprehensive experience with actionable takeaways.
We ask leading experts in the field what eye disease they would cure and why.
The start of the series that asks leading experts in the field what eye disease they would cure and why.
Identifeye HEALTh is taking on retinal imaging, enhancing accessibility and integrating AI to improve patient care and streamline healthcare workflows.
Ahead of the September 8 meeting in Paris, the program co-chair of the event and current president of the American Academy of Ophthalmology discusses how the workshop aims to shape consensus on guidelines, research priorities, and emerging therapies in myopia control.
In episode 1, Bill Trattler, MD, shares practical advice on documentation, patient communication, keratoconus management, and advanced lens technology.
Extend the summer at EyeCon 2025—where clinical insight meets coastal vibes—September 26 and 27 at the Margaritaville Hollywood Beach Resort in Florida.
Jay Chhablani, MD, presented the phase 1/2 clinical trial data for OCU410, at the 2025 annual meeting of the American Society of Retina Specialists.
At ASRS 2025, Andrew G Lee, MD, gave key insight into the world of a neuro-ophthalmologist and why and when a retina specialist should consult a neuro-ophthalmologist
